Bioyitech made its debut at Vitafoods Asia 2025, accelerating its overseas market expansion with a one-stop "Chinese Bacteria" solution.
From September 17th to 19th, Vitafoods Asia 2025, a leading trade show for the Asian nutraceutical industry, took place at the Queen Sirikit National Convention Center in Bangkok. Bioyitech showcased over 30 high-activity probiotic raw materials and finished product solutions for the first time. Targeting buyers from Southeast Asia, the Middle East, and Europe and the United States, the company presented its mature products in areas such as "sugar-lipid-acid metabolism, gut health, and weight management," attracting numerous professional visitors for discussions. Bioyitech also reached cooperation intentions with several overseas clients, further expanding its international market channels.
1. A collection of 6,000 strains + 9 invention patents, holding "core strains" in its own hands.
Relying on Professor Zhang Lanwei of Ocean University of China's 30 years of original scientific research accumulation, Bioyitech has built one of the high-standard private strain libraries in China, preserving more than 6,000 strains, including 102 functional strains and 9 invention patents (including GLP-1 targeting bacteria, uric acid-degrading bacteria, etc.). The "star trio" of this exhibition all came from its own library:
ZC-URA High Uric Acid Degrading Bacteria: Completed clinical trials with the Second People's Hospital of Guangdong Province.
ZC-SUG "Semaglutide Bacteria" GLP-1 Targeting Combination: Clinical trials are about to be completed with the Second Hospital Affiliated to Zhejiang University School of Medicine.
ZC-SLM Three-Lipid Elimination Bacteria: Alleviates the enlargement of fat cells and triglycerides and total cholesterol in the blood caused by a high-fat diet through the semaglutide pathway.
2. Hundred-level cleanliness + trillion-level high-density culture, pharmaceutical-grade production capacity escort.
The company's Shanghai Fengxian factory, with a first phase of 4,300 m², has 5 fully automatic intelligent production lines. The core workshop is hundred-level clean, adopting three core technologies: "trillion-level high-density culture + micro-ice crystal freeze-drying + directional reactivation," and the viability stability of Live Bacteria far exceeds the industry average. The factory has passed multiple certifications such as FDA, FSSC22000, SEDEX, and HALAL and has obtained export qualifications, providing ODM/OEM services for more than 60 leading brands such as Bright Dairy, Feihe, Yili, Sirio, and Aland.
3. From "selling bacterial powder" to "selling solutions," ODM one-click to go global.
Addressing the pain points of overseas customers' domestic procurement, Bioyitech will provide:
Formula Pool: Ready-made 30+ functional formulas (gut health, metabolism, oral whitening, sports nutrition, etc.) have all completed small-scale, pilot-scale, and stability verification, allowing customers to "select and use immediately."
Packaging Library: A professional design team + hundreds of editable PSD source files, covering conventional packaging such as stick packs, bar packs, capsule bottles, and chewable tablet cans, supporting one-click language replacement, code replacement, and LOGO replacement, with visual implementation completed in as fast as 3 days.
Certification Chain: The factory already holds FDA, FSSC22000, SEDEX, and HALAL certificates and can simultaneously provide COA, stability data, and heavy metal and pesticide residue reports, meeting the registration requirements of more than 90% of Southeast Asian countries.
Regulatory Package: Each formula is equipped with regulatory materials in multiple languages in addition to Chinese and English, including ingredient compliance analysis, nutrition facts table, health claim recommendations, halal (HALAL) certification templates, and FDA filing document frameworks, which can be directly implemented for production.